CA Stock MarketDetailed Quotes
INNO InnoCan Pharma Corp
- 0.210
- 0.0000.00%
15min DelayMarket Closed Dec 13 11:39 ET
60.26MMarket Cap-17.50P/E (TTM)
0.210High0.210Low2.50KVolume0.210Open0.210Pre Close525.00Turnover0.34052wk High0.00%Turnover Ratio286.94MShares0.18552wk Low-0.012EPS TTM46.55MFloat Cap1.650Historical HighLossP/E (Static)221.67MShs Float0.050Historical Low-0.023EPS LYR0.00%Amplitude--Dividend TTM8.08P/B1Lot Size--Div YieldTTM
About InnoCan Pharma Corp Company
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Company Profile
SymbolINNO
Company NameInnoCan Pharma Corp
Founded2018
MarketCNQ
Employees9
Fiscal Year Ends12-31
Address1015, 926 - 5 Avenue SW
CityCalgary
CountryCAN
Zip CodeT2P 0N7
Phone+1 403 777-1519
Company Executives
- Name
- Position
- Salary
- Iris Bincovich
- Chief Executive Officer and Director
- --
- Ron Mayron
- Executive Chairman of the Board
- --
- Roni Kamhi
- Director and Member of the Management Board
- --
- Ralph C.l. Bossino
- Director
- --
- Joshua Lintern
- Director
- --
- Eyal Kalo
- Research and Development Director
- --
- Peter Bloch
- Director
- --
- Eyal Flom
- Director
- --
- Nelson Halpern
- Member of Management Board
- --
Heat List
CA
Overall
Symbol
Price
% Chg
No Data